12:32 PM EST - AEterna Zentaris Inc. : slipped to a fourth-quarter loss on Wednesday due to higher research and development expenses and a lower income tax recovery rate. The biopharmaceuticals company said it lost $13.6 million, or 26 cents a share in the period ended December 31, compared with a profit of $39.1 million, or 74 cents a share, during the same period a year earlier. Revenue for the quarter was $10.2 million, down 14.2 percent from $11.9 million in the same period in 2006. Analysts were expecting a loss of 19 cents a share on revenue of $10.5 million. AEterna Zentaris Inc.
shares T.AEZ are trading down 1 cent at $1.29.
